2023
DOI: 10.1016/j.isci.2023.106669
|View full text |Cite
|
Sign up to set email alerts
|

Conditional deletion of LRRC8A in the brain reduces stroke damage independently of swelling-activated glutamate release

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
13
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
2

Relationship

2
4

Authors

Journals

citations
Cited by 8 publications
(14 citation statements)
references
References 84 publications
(141 reference statements)
1
13
0
Order By: Relevance
“…Previous studies have shown LRRC8A subunits was most important for macrophage/microgliamediated injury as a transport for glutamatergic input, ATP and cGAMP [35,36]. However, a recent study showed that LRRC8A contributed to ischemic brain injury via the mechanism other than VRAC-mediated glutamate release, considering that LRRC8A played a regulatory role in signaling pathway [15]. S1PR1, a G-protein coupled receptor which was activated by S1P, widely expressed in nervous system and plays an immunomodulatory role through downstream signaling pathways [28,37].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Previous studies have shown LRRC8A subunits was most important for macrophage/microgliamediated injury as a transport for glutamatergic input, ATP and cGAMP [35,36]. However, a recent study showed that LRRC8A contributed to ischemic brain injury via the mechanism other than VRAC-mediated glutamate release, considering that LRRC8A played a regulatory role in signaling pathway [15]. S1PR1, a G-protein coupled receptor which was activated by S1P, widely expressed in nervous system and plays an immunomodulatory role through downstream signaling pathways [28,37].…”
Section: Discussionmentioning
confidence: 99%
“…The widely accepted idea that LRRC8A subunits are most important for the VRAC to increase glutamatergic input after brain injury and non-speci c VRAC blockers or conditional knockout of LRRC8A may play a neuroprotective role in rodent models of stroke [13,14]. However, a recent study showed that LRRC8A contributed to ischemic brain injury via the mechanism other than swelling-activated VRACmediated glutamate release by the brain-wide LRRC8A deletion and astrocytic LRRC8A knockout, considering that LRRC8A played a role in signaling pathway as a regulatory protein [15]. Meanwhile, our previous research also found that LRRC8A, as a regulatory protein played a role in the cardiovascular system by its LRRD [16,17].…”
Section: Introductionmentioning
confidence: 99%
“…It is also important to note that recent studies have challenged the primary narrative of VRAC-mediated glutamatergic excitotoxicity. One group found that the total deletion of LRRC8A in nestin + cells resulted in complete loss of VRAC-mediated glutamate release, whereas heterozygous knockout animals exhibited full swell-activated glutamate release ( Balkaya et al, 2023 ). Despite this difference, both full and heterozygous knockout animals displayed identical protection against ischemia in an experimental stroke model, suggesting VRAC ablation may exert its neuroprotective function through nonglutamatergic mechanisms ( Balkaya et al, 2023 ).…”
Section: Discussionmentioning
confidence: 99%
“…Given that VRAC inhibitors and LRRC8A gene disruption reduce ischemic neuronal injury (Balkaya et al, 2023;Feng et al, 2004;Kimelberg et al, 2000;Kimelberg et al, 2003;Yang et al, 2019;Zhang et al, 2008;Zhou et al, 2020), we also investigated whether selective neuronal LRRC8A gene disruption blocks neuronal oxidative stress during cortical ischemia-reperfusion.…”
Section: Requisite Role For Neuronal Vracs In Nmda-and Ischemia-induc...mentioning
confidence: 99%
“…VRAC inhibitors have long been recognized as neuroprotective in rodent stoke models (Balkaya et al, 2023;Feng et al, 2004;Kimelberg et al, 2000;Zhang et al, 2008). This effect was initially ascribed to inhibition of excitotoxic glutamate release from astrocyte VRACs (Phillis et al, 1998;Seki et al, 1999;Zhang et al, 2008); however, VRACs are a relatively minor route of glutamate efflux during ischemia (Rossi et al, 2000;Swanson et al, 2004), and more recent work shows a poor correlation between VRAC-mediated glutamate release and ischemic neuronal injury (Balkaya et al, 2023).…”
Section: Introductionmentioning
confidence: 99%